Emens LA, Loi S, Rugo HS. et al.
IMpassion130: Efficacy in immune biomarker subgroups from the global, randomized, double-blind, placebo-controlled, phase III study of atezolizumab + nab-paclitaxel in patients with treatment-nave, locally advanced or metastatic triple-negative breast cancer.
San Antonio Breast Cancer Symposium 2018; Abstr. GS1-04
Download Bibliographical Data